A2213
The A2213 is a lab equipment product from Harvard Bioscience. It is designed for general laboratory use. The core function of the A2213 is to provide a precise and reliable measurement tool for various applications in the bioscience field.
Lab products found in correlation
3 protocols using a2213
Isolation and Culture of Primary Human Dermal Fibroblasts
Rapamycin Impacts Metastatic Breast Cancer
The experimental design was determined as the MDA-MB 231-control group (MDA-MB 231 metastatic breast cancer cells without exposure to any drug), MCF-7-control group (MCF-7 non-metastatic breast cancer cells without exposure to any drug); MDA-MB 231-Rapamycin group (MDA-MB 231 metastatic breast cancer cells treated with 1 ug/ml Rapamycin) and MCF-7-Rapamycin group (MCF-7 non-metastatic breast cancer cells treated with 1 ug/ml Rapamycin) evaluated the effect of 24-hour Rapamycin treatment.
Isolation of Primary Dermal Fibroblasts
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!